Metraipolis › archive › dc_3ebcf7f892b8
Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation — Europe PMC PMID:42042770
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42042770
- DOI
- 10.3390/vaccines14040295
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T21:17:09.860Z
- SHA-256 of the archived text
327d5ea6cda3840051f07c8fa5cfeaa81680ce889e0a49a1d6e4892f27c1441a- Stable URL of this page
https://metraipolis.com/documento/dc_3ebcf7f892b8
How to cite
Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation — Europe PMC PMID:42042770 — Europe PMC (en), https://europepmc.org/article/MED/42042770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ebcf7f892b8 (Metraipolis archive dc_3ebcf7f892b8, sha256 327d5ea6cda3840051f07c8fa5cfeaa81680ce889e0a49a1d6e4892f27c1441a)
BibTeX
@misc{dc3ebcf7f892b8,
title = {Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation — Europe PMC PMID:42042770},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42042770},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ebcf7f892b8; sha256 327d5ea6cda3840051f07c8fa5cfeaa81680ce889e0a49a1d6e4892f27c1441a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42042770. Agents can read the archived copy with the MCP tool read_document.